Navigation Links
AGD Concerned With Presidential Veto of SCHIP Reauthorization Bill
Date:10/4/2007

s bill will be a "scorecard component" when the AGD grades lawmakers serving in the 110th Congress on their commitment to basic oral health care services for all. "This veto was a missed opportunity to protect the health of our nation's most vulnerable population -- the children," Kopenhaver concluded. Myron J. Bromberg, DDS, chair of AGD's Legislative and Governmental Affairs Council, notes that, while an override is hoped for, it may not occur for political reasons; Republican legislators will have to decide if they will vote to override a veto by a Republican president.

Dental care is a basic and necessary health care service for children, and can prevent systemic and oral disease. Early and preventive treatment has a proven track record of cost effectiveness, especially among low-income children. The success of SCHIP in decreasing the number of uninsured children has significantly improved the health-status of children from lower-income families; this program needs to be continued.

The SCHIP was authorized by Congress in 1997 to expand public health care availability to low-income children and families. At that time, SCHIP gave $40 billion to states for 10 years to provide coverage for children living in families who earned too much to qualify for Medicaid, but not enough to afford private insurance. Today, this successful program covers more than six million children.

About the AGD

The AGD is a professional association of more than 35,000 general dentists dedicated to staying up-to-date in the profession through continuing education. Founded in 1952, the AGD has grown to become the world's second largest dental association, which is the only association that exclusively represents the needs and interests of general dentists.

More than 772,000 persons are employed directly in the field of dentistry. A general dentist is the primary care provider for patients of all ages and is responsible for the diagnosis, treatment, management and
'/>"/>

SOURCE The Academy of General Dentistry
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Scientists Concerned Over Increasing Malfunction Of Heart Devices
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Parents Concerned About Pesticide And Cancer Risk To Babies
4. Executed Prisoner Organs For Sale In China: BTS Concerned
5. Meth Addiction On The Rise, US Health Authorities Concerned
6. Centre Concerned over Spurt in Polio Cases
7. Swaraj concerned over developments concerning AIIMS
8. Parents Concerned over 16-month-old boy’s Overweigh
9. British Teachers Concerned About Primary School kid’s Sexual Behavio
10. Singer Richie Concerned over Daughters Weight Loss
11. How to Bell the Fat? –Most U.S Citizens Concerned, Reveals Surve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...fering from the most common form of brain cancer m...y and // chemotherapy than radiotherapy alone . Ba... people with the type of cancer known as glioblast... the cancer as safely possible and then undergo ra...
...g the opinion that dairy products provide the nece...In a study conducted recently on collected informa...children and adolescence and consumption of dairy ...ip between the two. Children are often advised to ...
...nted at American College of Cardiology, laughter c...ief presenter of the paper Michael Miller, MD, dir...associate professor of medicine at the University ...sion after studying 300 participants, 150 healthy ...
...y thought of as a characteristic trait of man. Oft...ly acceptable attributes of man. But can it be lin...ecent study in the current issue of Biological Psy... ratio is the ratio of second finger or index fing...
Other Medicine News:
(Date:8/28/2008)... VIENNA, Austria, Aug. 28 /- Inte...aborator Merck & Co., Inc. has initiated a Phase I...ne for the prevention of,Staphylococcus aureus (S....,placebo controlled study aims to evaluate the saf... patients with end-stage kidney disease on,hemodia...
(Date:8/27/2008)... - Patients in the VELCADE, melphalan and predn...nefit as well as a 30 percent complete response -,...nium: The Takeda,Oncology Company today announced ...andomized, Phase III VISTA(1) trial in this week,s...he results showed a significant survival,benefit a...
(Date:8/27/2008)... - First Phase 3 data, from BLISS-52 trial, e...trial, BLISS-76, expected by fall 2009 -, ROCKVIL...enome,Sciences, Inc. (Nasdaq: HGSI ) today announ... in BLISS-76, the second of two pivotal Phase 3,ra...umab) in patients with,active systemic lupus eryth...
(Date:8/26/2008)... INDIANAPOLIS, Aug. 26 /- Semafor...th International Congress on Targeted Therapies,in...ery of novel,multi-targeted kinase inhibitors that...eclinical studies., A novel and proprietary molec...al modeling allowing for the design of pan-PI3 kin...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 1Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 2Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 3Spectranetics to Appeal Decision in Patent Litigation 1160 1Spectranetics to Appeal Decision in Patent Litigation 1160 2Spectranetics to Appeal Decision in Patent Litigation 1160 3Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year 552 1Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year 552 2ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference 550 1ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference 550 2
... Calif.--(BUSINESS WIRE)--Jun 11, 2007 - Geron,Cor...ation of,research studies indicating that GRNOPC1,...sed therapeutic for the treatment of,spinal cord i...system., Presented by Geron scientist Ross Okamura...s meeting in San Diego, the findings,could mean th...
..., June 11, 2007-ReGen is pleased to announce that,... Colostrinin, its,nutraceutical product which the ...thy cognitive function, was presented today at the...n Surfers,Paradise, Queensland, Australia by Dr Ma...he conference, which is being attended by key opin...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
...clusive Measuring System delivers precise and accu...eel they are receiving a better examination when t...ipment. ,User Friendly - after only 5 minutes of...ome very proficient in the operation of this instr...
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve
Medicine Products: